Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.725
-0.015 (-0.86%)
At close: Feb 27, 2026, 4:00 PM EST
1.730
+0.005 (0.29%)
After-hours: Feb 27, 2026, 7:41 PM EST

Silexion Therapeutics Stock Forecast

SLXN's stock price has decreased by -90% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Silexion Therapeutics stock have an average target of 40.5, with a low estimate of 6.00 and a high estimate of 75. The average target predicts an increase of 2,247.83% from the current stock price of 1.73.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $40.5 $75 $75
Change +247.83% +2247.8% +4247.8% +4247.8%
* Price targets were last updated on Dec 15, 2025.

Analyst Ratings

The average analyst rating for Silexion Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26
Strong Buy 1222
Buy 0000
Hold 0000
Sell 0000
Strong Sell 0000
Total 1222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Litchfield Hills
Litchfield Hills
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +247.83% Dec 15, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$135$75
Strong Buy Maintains $135$75 +4,247.83% Mar 20, 2025
Maxim Group
Maxim Group
Strong Buy
Initiates
$135
Strong Buy Initiates $135 +7,726.09% Nov 1, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.16
from -395.36
EPS Next Year
-4.48
from -6.16
Fiscal Year FY 2012 FY 2013 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2012 Dec 31, 2013 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
----395.36-6.16-4.48-4.82
EPS Growth
-------
Forward PE
-------
No. Analysts ----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027
High - -
Avg - -
Low - -

EPS Forecast

EPS 20252026202720282029
High -4.02 -4.19
Avg -6.16 -4.48
Low -8.08 -4.70

EPS Growth

EPS Growth 20252026202720282029
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.